Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review

Abstract Background Since the implementation of the Regulation on Patient Integration (2003), the Act on the Reorganization of the Pharmaceutical Market (2011), and the Patient Rights Law (2013), the inclusion of patient perspectives has been further anchored in the German early benefit assessment p...

Full description

Bibliographic Details
Main Authors: Ana Babac, Kathrin Damm, J.-Matthias Graf von der Schulenburg
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Health Economics Review
Subjects:
Online Access:https://doi.org/10.1186/s13561-019-0251-9